Nuanced treatment decision in newly diagnosed multiple myeloma patients aged 65-75 years: a real-world study
{{output}}
Purpose: The optimal treatment strategy for patients aged 65-75 years with multiple myeloma (MM) remains undefined, as most clinical trials involving transplant-eligible patients have excluded this subgroup. We investigated the r... ...
